ReviewNew microbes and new infections2015
The global threat of antimicrobial resistance: science for intervention.
Review in New microbes and new infections, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT04848883 (Infectious Diseases Experts as Part of the Antibiotic Stewardship Team in Primary Care), which is not on this map. Cited by 422 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Infectious Diseases Experts as Part of the Antibiotic Stewardship Team in Primary Care: a Cluster-randomised Blinded Study (IDASP)
Who cites it
422 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The efficacy of systemic antibiotics as an adjunct to surgical treatment of peri-implantitis: a systematic review.BMC oral health · 2021Pooled it
- Supercritical CORSC advances · 2026Article
- Effectiveness of Clinical Pathway Pop-Up Window Insertion in Computer-Based Prescription System for Antibiotic Stewardship in Acute Diarrhea.Infection & chemotherapy · 2026Article
- Leuconostoc mesenteroides TH-ST373 Cell-Free Supernatant Against Multidrug-Resistant Escherichia coli.Probiotics and antimicrobial proteins · 2026Article
- Observational
- Advanced Mathematical Methods in Dental Bioengineering and Biomaterials Machining.Biomimetics (Basel, Switzerland) · 2026Review
- Agave-Derived Carbon Dots Incorporated into PVA/Chitosan Nanofibers for Prolonged Antibacterial Activity.ACS omega · 2026Article
- Isolation, antimicrobial evaluation, and in silico docking of spinasterol from Impatiens rothii Hook. f. tuber extract.Tropical medicine and health · 2026Article
- Microplastics as active modulators ofBiofilm · 2026Article
- Building behaviour change systems for antimicrobial resistance response in Nigeria by leveraging insights from mass gatherings awareness efforts (2017-2023).Mass gathering medicine (Amsterdam, Netherlands) · 2026Article
- Human antibodies as emerging drugs for antimicrobial resistance.Trends in immunology · 2026Review
- Selective Photodisinfection of Bacteria and Biofilms Using Blue Light-Activated Molybdenum Nanoclusters via Dual Singlet Oxygen and Hydroxyl Radical Sensitization.Inorganic chemistry · 2026Article
- Metagenomic analysis of bacterial diversity, antibiotic resistance, and functional profiles in the ice core samples from two glaciers of Sikkim Himalaya.Scientific reports · 2026Article
- Antimicrobial resistance and gene therapy: emerging molecular strategies for a global health threat.Gene therapy · 2026Review
- Article
- Phenotypic Antimicrobial Resistance of Some Bacterial Strains Isolated from Red Foxes (Antibiotics (Basel, Switzerland) · 2026Article
- Antimicrobial Resistance: How Can We Overcome the Problem?Antibiotics (Basel, Switzerland) · 2026Review
- Antimicrobial Activity of Bioactive Peptides on Resistant Enterobacteriaceae and the Viability ofVeterinary sciences · 2026Article
- The Global Epidemiology of Antimicrobial Resistance: Trends, Determinants, and Public Health Implications.Cureus · 2026Review
- Article
362 more citing papers are in PubMed but not listed here.
Corrections and comments
- Erratum issued
Authors and funding
24 authors.
Funding
Abstract
In the last decade we have witnessed a dramatic increase in the proportion and absolute number of bacterial pathogens resistant to multiple antibacterial agents. Multidrug-resistant bacteria are currently considered as an emergent global disease and a major public health problem. The B-Debate meeting brought together renowned experts representing the main stakeholders (i.e. policy makers, public health authorities, regulatory agencies, pharmaceutical companies and the scientific community at large) to review the global threat of antibiotic resistance and come up with a coordinated set of strategies to fight antimicrobial resistance in a multifaceted approach. We summarize the views of the B-Debate participants regarding the current situation of antimicrobial resistance in animals and the food chain, within the community and the healthcare setting as well as the role of the environment and the development of novel diagnostic and therapeutic strategies, providing expert recommendations to tackle the global threat of antimicrobial resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.